{
  "case_id": "Case_4",
  "model_id": "microsoft/wizardlm-2-8x22b",
  "content": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"McArdle Disease (Glycogen Storage Disease type V)\",\n        \"confidence\": 0.8,\n        \"icd_code\": \"E74.0\",\n        \"reasoning\": \"Exercise intolerance, intermittent muscle weakness, elevated CK levels, and dark urine following intense exercise are classic symptoms. The patient's parents are consanguineous, which increases the risk of autosomal recessive disorders like McArdle Disease.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Carnitine Palmitoyltransferase Deficiency (CPT Deficiency)\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"E71.4\",\n            \"reasoning\": \"Similar presentation with exercise-induced muscle pain and weakness, and can be associated with myoglobinuria (dark urine).\"\n        },\n        {\n            \"name\": \"Mitochondrial Myopathy\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"Unknown\",\n            \"reasoning\": \"Can present with exercise intolerance and muscle weakness, although less likely given the specific pattern of symptoms related to exercise.\"\n        },\n        {\n            \"name\": \"Duchenne Muscular Dystrophy\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"G71.0\",\n            \"reasoning\": \"Typically presents earlier in life, but can have a milder course in some individuals. Elevated CK levels are a feature.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Exercise intolerance with muscle weakness\",\n        \"Intermittent dark urine after intense exercise\",\n        \"Elevated CK levels during episodes\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Muscle biopsy with histochemical analysis and electron microscopy\",\n            \"purpose\": \"To confirm the presence of glycogen storage abnormalities\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Genetic testing for mutations in the PYGM gene\",\n            \"purpose\": \"To confirm diagnosis of McArdle Disease\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Blood lactate levels during and after exercise\",\n            \"purpose\": \"To evaluate for a normal or low increase in lactate, which is indicative of McArdle Disease\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Avoid strenuous exercise until diagnosis is confirmed\",\n            \"Educate patient and family about symptoms and potential triggers\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Sucrose (oral)\",\n                \"dose\": \"Variable, based on patient tolerance and response\",\n                \"route\": \"PO\",\n                \"duration\": \"Long-term\",\n                \"rationale\": \"May improve exercise tolerance in McArdle Disease by providing an alternative energy source\"\n            }\n        ],\n        \"monitoring\": [\n            \"CK levels\",\n            \"Frequency: As indicated by symptoms and exercise regimen\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Genetics\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"To confirm diagnosis and provide genetic counseling to the patient and family\"\n            },\n            {\n                \"specialty\": \"Neurology\",\n                \"urgency\": \"routine\",\n                \"reason\": \"For further evaluation and management of neuromuscular symptoms\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Persistent muscle weakness\",\n        \"Worsening renal function (secondary to myoglobinuria)\"\n    ],\n    \"patient_education\": [\n        \"Avoidance of high-intensity exercise to prevent muscle damage\",\n        \"Importance of maintaining hydration and possibly a modified diet\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"1-2 weeks after initial assessment\",\n        \"conditions\": \"New onset of muscle weakness, persistent dark urine, or worsening renal function\"\n    },\n    \"confidence_in_assessment\": 0.7,\n    \"uncertainties\": [\n        \"Exact genetic mutation and its implications for disease severity and management\",\n        \"Potential for other metabolic or mitochondrial disorders that could present similarly\"\n    ]\n}\n```",
  "latency": 35.40441608428955,
  "timestamp": "2025-08-10T01:17:39.649882",
  "cached_at": "2025-08-10T01:17:39.649889"
}